Colospan
Grant-FundedCORDISInnovative solutions for colorectal surgery to prevent clinical leakage
Digital Health
Anastomotic leakage of colon content into the abdominal cavity is the most devastating complication associated with colorectal surgery. Leaks occur in ~22% of cases, leading to increased hospitalization time, higher re-operation rates, increased patient mortality & additional costs.
To minimize the risk of a leak, surgeons create a loop of the small bowel which is diverted outside the abdominal wall & connected to a stoma bag to collect patient’s feces for 4-6 months. Diverting stoma significantly diminishes patients’ quality of life, increases cost of care &
requires an additional invasive surgery to reverse the stoma. Our novel device, CG-100, is an elastic tubular sheath that is positioned at the anastomosis site during the primary colorectal surgery & creates an internal bypass for all colon content. CG-100 is removed non-surgically 10
days after primary surgery. CG-100 addresses will improve patient quality of life, save ~1350 pa lives & reduce healthcare costs by €4B pa in EU.
EU Grants€2.3M
Open to funding
Team
BA
Boaz Assaf
Founder
All-time revenue—
MRRPrivate••••••
FounderBoaz Assaf
Founded—
🇮🇱Israel
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Business detailsB2B
Digital Health
Tags:Digital Health
Looking for:InvestmentPartnerships
Company Info
Colospan Info
Funding
EU Grants€2.3M
Open to funding
